Target intelligence / Profile preview

Semipermeable dialysis membrane

Molecular classification
Other, Polymer material
01

Overview

A semipermeable dialysis membrane is a thin, selective barrier used in hemodialysis and peritoneal dialysis to replicate the filtration function of the human kidney. It allows for the passage of small solutes such as urea, creatinine, and electrolytes through diffusion and convection while preventing the loss of larger, essential blood components like albumin and blood cells (StatPearls, 2023). These membranes are typically manufactured from synthetic polymers like polysulfone or polyethersulfone, or from modified natural materials like cellulose acetate, designed to minimize adverse immune reactions (NIH, 2022). Although it is a medical device component rather than a biological molecular target, its performance is vital for managing end-stage renal disease and acute kidney injury. The membrane's surface chemistry can interact with systemic drugs, most notably anticoagulants like heparin, which are required to prevent blood clotting within the extracorporeal circuit (PubMed, 2021). Modern high-flux membranes also allow for the removal of middle-sized molecules like beta-2 microglobulin, which can otherwise accumulate and cause dialysis-related amyloidosis. The selection of membrane material is a critical clinical decision based on the patient's inflammatory status and the required clearance rates.

Other names
Dialysis membraneHemodialysis membraneArtificial kidney membraneSelective permeable membrane
02

Mechanism of action

Facilitates the removal of metabolic waste products and excess electrolytes from the blood via passive diffusion and convective transport (ultrafiltration) across a selective barrier.

03

Biological functions

OtherFiltrationDiffusionOsmosis
04

Disease associations

OtherEnd-stage renal diseaseAcute kidney injuryKidney failure
05

Safety considerations

Biocompatibility issuesComplement activationThrombosisFirst-use syndromeInflammatory response
06

Interacting drugs

Heparin

4 more in the full profile.

07

Biomarkers

Urea reduction ratio (URR)Kt/V (dialysis adequacy)Creatinine clearanceBeta-2 microglobulin levels

Beyond the preview

Go deeper on Semipermeable dialysis membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Semipermeable dialysis membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call